SHANGHAI FOSUN PHARMACEUTICAL (GROUP) revenue breakdown overview

SHANGHAI FOSUN PHARMACEUTICAL (GROUP) revenue for the last year amounted to 41.25 B CNY, the most of which — 30.22 B CNY — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 30.81 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought SHANGHAI FOSUN PHARMACEUTICAL (GROUP) 31.03 B CNY, and the year before that — 30.01 B CNY.